CNA Financial’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

CNA Financial’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-9,403	Closed	-$252K	–	195
2022 Q1	$252K	Buy	9,403 +320	+4%	+$10.8K	0.08%	176
2021 Q4	$433K	Buy	9,083 +3,060	+51%	+$137K	0.11%	170
2021 Q3	$400K	Sell	6,023 -1,620	-21%	-$115K	0.11%	175
2021 Q2	$596K	Buy	7,643 +1,340	+21%	+$99K	0.17%	150
2021 Q1	$596K	Buy	6,303 +650	+11%	+$77.3K	0.18%	149
2020 Q4	$689K	Sell	5,653 -630	-10%	-$69K	0.22%	133
2020 Q3	$549K	Sell	6,283 -167	-3%	-$11.6K	0.2%	122
2020 Q2	$417K	Buy	+6,450	New	+$372K	0.17%	143

Other funds holding TPTX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

CNA Financial's TPTX Position: Q2 2022 in Review

CNA Financial sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q2 2022, closing a stake of 9,403 shares — an estimated $252K sold.

CNA Financial first reported a position in TPTX in Q2 2020 and held it in 8 quarters. The position peaked at $689K in Q4 2020. 208 funds tracked by Wall St. Rank hold TPTX as of Q2 2022.

CNA Financial reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
CNA Financial sold 9,403 Turning Point Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $252K.
CNA Financial first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q2 2020 and held it in 8 quarters.
CNA Financial's Turning Point Therapeutics, Inc. Common Stock position peaked at $689K in Q4 2020.
208 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q2 2022.

Based on CNA Financial's 13F filing for Q2 2022, filed 9 Aug 2022.